Bejelentkezés Regisztrálj ingyen

QSAM Biosciences Jövedelem

Mi az QSAM Biosciences Jövedelem?

A Jövedelem az QSAM Biosciences, Inc. - -$8.73

Mi a Jövedelem meghatározása?

A közös részvényesek számára rendelkezésre álló nettó jövedelem egyenlő a nettó jövedelemmel mínusz a kifizetett előnyben részesített osztalékokkal.

Net income available to common shareholders are the profits remaining after the company pays all of its suppliers, employees, service providers, creditors, and preferred shareholders. In other words, this is revenue less all expenses and preferred dividends. The number measures common shareholders' claim on the company's cash flows.

Jövedelem a Health Care szektor a OTC-on cégekben a QSAM Biosciences -hoz képest

Mit csinál QSAM Biosciences?

QSAM Biosciences, Inc., a clinical stage biotechnology company, develops drugs for the treatment of bone cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage novel radiopharmaceutical for the treatment of bone cancer and related diseases. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was founded in 2004 and is based in Austin, Texas.

jövedelem -hoz hasonló cégek QSAM Biosciences